NCT00003435View on ClinicalTrials.gov

Antiviral Therapy Plus Either Peripheral Stem Cell or Umbilical Cord Blood Transplantation in Treating Patients Who Are HIV Positive and Have Hematologic Cancer

PHASE1WithdrawnINTERVENTIONAL
0
Timeline

Start Date

May 31, 1998

Conditions
LeukemiaLymphoma
Interventions
BIOLOGICAL

anti-thymocyte globulin

DRUG

melphalan

PROCEDURE

antiviral therapy

PROCEDURE

bone marrow ablation with stem cell support

PROCEDURE

peripheral blood stem cell transplantation

PROCEDURE

umbilical cord blood transplantation

RADIATION

radiation therapy

Trial Locations (1)

27710

Duke Comprehensive Cancer Center, Durham

Sponsors

Lead Sponsor

Duke University
All Listed Sponsors
collaborator

National Cancer Institute (NCI)

NIH

lead

Duke University

OTHER